Department of Cariology, Restorative Sciences and Endodontics, School of Dentistry, University of Michigan, Ann Arbor, MI, USA.
J Am Dent Assoc. 2011 May;142(5):493-504. doi: 10.14219/jada.archive.2011.0219.
The authors evaluated published evidence from controlled clinical trials regarding the efficacy of two local anesthetic solutions in providing successful pulpal anesthesia.
The authors searched MEDLINE and Embase databases to identify peer-reviewed randomized controlled trials in which researchers directly compared articaine and lidocaine local anesthetic solutions in adult participants. They extracted study characteristics and outcomes data as a basis for meta-analysis. They completed subgroup analyses for both infiltration and mandibular inferior alveolar block anesthetic techniques.
Articaine solutions had a probability of achieving anesthetic success superior to that of lidocaine, with an odds ratio of 2.44 (95 percent confidence interval [CI], 1.59-3.76; P < .0001). The greater odds ratio for articaine increased to 3.81 (95 percent CI, 2.71-5.36; P < .00001) when the authors analyzed only infiltration data. There was weaker, but still significant, evidence of articaine's being superior to lidocaine for mandibular block anesthesia, with an odds ratio of 1.57 (95 percent CI, 1.12-2.21; P = .009), and no difference when the authors considered only symptomatic teeth.
Research evidence supports using articaine versus lidocaine for achieving pulpal anesthesia when the infiltration mode of administration is used. It is premature to recommend articaine for mandibular block anesthesia in cases involving irreversible pulpitis.
作者评估了关于两种局部麻醉剂溶液在提供成功牙髓麻醉方面的疗效的已发表对照临床试验证据。
作者检索了 MEDLINE 和 Embase 数据库,以确定研究人员直接比较阿替卡因和利多卡因局部麻醉剂溶液在成年参与者中的随机对照试验。他们提取了研究特征和结局数据,作为进行荟萃分析的基础。他们完成了浸润和下颌下牙槽阻滞麻醉技术的亚组分析。
阿替卡因溶液具有优于利多卡因的麻醉成功率的可能性,优势比为 2.44(95%置信区间[CI],1.59-3.76;P<.0001)。当作者仅分析浸润数据时,阿替卡因的优势比增加到 3.81(95%CI,2.71-5.36;P<.00001)。对于下颌阻滞麻醉,阿替卡因仍优于利多卡因,但证据较弱,优势比为 1.57(95%CI,1.12-2.21;P=.009),而对于有症状的牙齿,两者没有差异。
研究证据支持在使用浸润给药模式时,使用阿替卡因代替利多卡因来实现牙髓麻醉。在涉及不可逆性牙髓炎的情况下,推荐阿替卡因用于下颌阻滞麻醉还为时过早。